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CASE REPORT
A 31-year-old man presented with a dry cough and exertional dyspnea. The chest X-ray showed multiple
nodular opacities throughout the entire lung field. Chest computed tomography (CT) revealed variable-sized
nodules with a peribronchiolar or centrilobular distribution, some of which revealed thick-walled cavitary change.
Based on the chest CT findings, it was initially assumed that metastatic lung nodules with hematogenous spread
were present; therefore, we performed an open lung biopsy. On microscopic examination, several compact
cellular interstitial infiltrates composed of Langerhans’ cells, eosinophils, and lymphocytes were observed.
Immunochemically, the Langerhans’ cells showed strong cytoplasmic staining for S-100 protein. Based on these
findings, the patient was diagnosed with Langerhans’ cell histiocytosis of the lung. High-resolution CT of the
chest is a useful, sensitive tool in the diagnosis of pulmonary Langerhans’ cell histiocytosis (PLCH). A typical
radiologic finding of PLCH is irregularly shaped cysts. The radiological finding in this case of nodular opacities
throughout the lung fields only without cysts is rare in PLCH. We report a case of PLCH with atypical multiple
nodules mimicking hematogenous metastatic lung nodules. (Korean J Intern Med 2009;24:393-396)
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INTRODUCTION
Langerhans’ cell histiocytosis (LCH) is a proliferative
disease characterized by monoclonal proliferation and the
infiltration of organs with Langerhans’ cells [1]. Several
organ systems may be involved in LCH including the
lungs, bone, skin, pituitary gland, liver, lymph nodes, and
thyroid [1]. Localized forms of LCH in bone have been
referred to as eosinophilic granuloma since Lichtenstein
first described them in 1940 [2]. The term “pulmonary
Langerhans’ cell histiocytosis (PLCH)” was first coined by
Farinacci in 1951 [3] and refers to disease in adults that
affects the lungs, either in isolation or in addition to other
organ systems [3]. Multi-systemic variants of this disease
are known by a variety of names, including systemic
histiocytosis X, Letterer-Siwe disease, and Hand-Schuller-
Christian disease [4]. To avoid confusion, the Histiocyte
Society has established a simplified classification system
[5]. According to this system, PLCH is a disease in adults
that affects the lungs, either in isolation or in addition to
other organ systems [5].
The most common findings on high-resolution computed
tomography (HRCT) of the chest are multiple nodular and
cystic changes, which occur predominantly in the middle
and upper lobes [6,7]. Nodular lesions are predominant in
the early stage of PLCH and progress to cystic lesions in
later stages of the disease [8]. In Korea, multiple cystic
lesions are the main radiological findings of PLCH, and no
cases with multiple nodular lesions without cysts have
been reported [9,10]. Here, we report a case of PLCH with
multiple nodules without cysts throughout the lungs.CASE REPORT
A 31-year-old male was admitted to our hospital for a
cough and exertional dyspnea, which had been present
for 2 months. He had no hypertension, tuberculosis, or
diabetes, and no history of surgery, medication, or travel.
He was a current smoker and a social drinker. He did not
appear ill, and his mental state was normal. His vital
signs were blood pressure 120/80 mmHg, pulse 84/minites,
respiration rate 20/minites, and body temperature 37.2˚C.
Physical examination of the head and neck revealed no
palpable cervical lymph nodes or masses and no neck vein
engorgement. Auscultation of the chest revealed a regular
heart beat with no murmurs and clear breath sounds with
no crackles or wheezing. The abdomen was soft and flat,
with no palpable mass or tenderness. Physical examination
of both extremities showed no finger clubbing, cyanosis,
or edema.
Laboratory examination indicated a white blood count
of 10,310/mm
3, hemoglobin concentration of 16.0 g/dL,
and platelet count of 202,000/µL, and the chemistry was
unremarkable. Arterial blood gas analysis revealed a pH of
7.455, PaO2 99.1 mmHg, PaCO2 38.2 mmHg, HCO3 27
mmol/L, and 98% O2 saturation. The results of the
pulmonary function test were forced vital capacity (FVC)
5.46 L/minites (105% of predicted), forced expiratory
volume in 1 second (FEV1) 4.59 L/minites (110% of
predicted), and FEV1/FVC 84%. We performed fiber optic
bronchoscopy for bronchoalveolar lavage and observed no
abnormal findings in the Gram stain or culture, acid-fast
bacillus stain or culture, tuberculosis-PCR, or cytology.
Chest radiography revealed multiple nodular opacities
in the upper and middle lungs (Fig. 1A). The chest CT
revealed variable-sized nodules with peribronchiolar or
centrilobular distribution, some of which revealed thick-
walled cavitary change (Fig. 2). The differential diagnosis
based on the chest CT findings was that the pulmonary
nodules represented hematogenous metastasis.
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Figure 1. Radiographic findings. (A) Simple chest radiograph shows multiple poorly defined nodular opacities in both lungs with
sparing the costophrenic area. (B) Chest radiograph after 15 months shows markedly decreased nodular opacities with remained
coarse reticular opacities in both upper lungs. (C) Coronal reconstructed imaging of chest CT shows multiple variable sized nodules
predominantly in both upper lungs. (D) Chest CT after 15 months reveals that previously noted lung nodules are disappeared. 
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C DWe performed an open lung biopsy at the right middle
and lower lobe. Histologically, multiple nodules showed
an infiltration of eosinophils, lymphocytes, and Langerhans’
cells (Fig. 3A). These cells stained with S-100 protein and
were compatible with LCH (Fig. 3B).
Treatment consisted only of smoking cessation, and a
chest radiograph 4 months later indicated that the nodules
had decreased in size. After 15 months, we observed that
the symptoms had improved further, and a follow-up
chest radiograph and HRCT indicated that the multiple
nodules had disappeared (Fig. 1D).
DISCUSSION
This case involved a young male who currently smoked
and had multiple pulmonary nodules, which were
suspicious of metastasis. However, the results of a biopsy
indicated PLCH. PLCH is a rare disorder found in only 5%
of biopsy-confirmed interstitial lung disease [1]. Vassallo
et al. [1] reviewed 102 cases with histopathologically
confirmed PLCH drawn from a group with a mean age of
40.3 years and a 1 : 1.5 ratio of males to females and found
that 95% of the cases involved smokers. Common symptoms
included a cough, dyspnea, and occasionally chest pain
[1].
No known genetic, occupational, or geographic risk
factors are associated with PLCH. The only consistent
epidemiologic association is cigarette smoking, which is
involved in the overwhelming majority (>90%) of cases
[1,10]. Several hypotheses have been proposed to explain
the association between cigarette smoking and PLCH.
According to one, cigarette smoke induces the secretion
of bombesin-like peptides from neuroendocrine cells in
the lungs [11]. These peptides may have an important role
in mediating lung injury and consequently induce lung
fibrosis [11]. Other components of cigarette smoke, such as
tobacco glycoprotein, have also been implicated in the
pathogenesis of PLCH [12]. Tobacco glycoprotein is an
immunostimulant that induces lymphocyte differenti-
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Figure 2. Axial chest computed tomography (CT) findings at the level of carina. Chest CT shows multiple nodules with peribronchial
or peribronchiolar location. Some nodules (arrowheads) have cavities with thick walls.
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Figure 3. Pathologic findings of the pulmonary nodules. (A) Pulmonary nodules are composed of Langerhans’ cells, lymphocytes, and
eosinophils (H&E, x400). (B) S-100 protein is positive in Langerhans’ cells (Immunohistochemistry, x100).
A Bation and lymphokine production [12]. Nevertheless,
PLCH occurs in a very small percentage of smokers, so
genetic or environmental factors likely contribute to the
development of this disease. A young male who currently
smoked complained of a cough and exertional dyspnea,
common clinical features of PLCH; however, the radio-
logical findings did not support a diagnosis of PLCH.
HRCT of the chest is a useful, sensitive tool in the
diagnosis of PLCH [1,13]. The combination of diffuse,
irregularly shaped cystic spaces with small
peribronchiolar nodular opacities, predominantly in the
middle and upper lobes, is highly suggestive of PLCH
[6-8,13]. When these features are present on HRCT, they
allow the clinician to make a diagnosis of PLCH without a
lung biopsy [1]. The lung cysts of PLCH are often less than
20 mm in diameter and typically have thin walls (<1 mm)
[6-8]. The frequency of cystic change reflects the timing
of imaging during the course of the disease [1,6-8]. In the
early stages, the most common finding is nodular change,
whereas in the later stages, cystic change and fibrosis
predominate [6-8].
Based on the radiological staging, this case represents
an early stage of PLCH comprised of nodular lesions only
without cystic change. This finding is rare; only one other
case of PLCH with multiple cavitating pulmonary nodules
has been reported [13], although several cases of PLCH
presenting as a solitary pulmonary nodule have been
reported worldwide [14]. None of these cases progressed
to a more severe stage, such as cystic change or reduced
pulmonary function [15]. Brauner et al. [8] reported two
cases of PLCH in which only nodules were present: one
progressed to cystic change and the nodular lesion disap-
peared in the other. It is thought that predominantly
nodular lesions in PLCH appear early in the reversible
state of the disease. In Korea, a number of cases of PLCH
have been reported based on variable radiological findings,
including multiple cysts and a combination of nodules
and cysts [9,10]. However, no case involving only nodular
lesions has been reported. Atypical radiological findings
as in this case need to be followed to determine whether
sarcoidosis, pneumoconiosis, military tuberculosis, hyper-
sensitivity pneumonitis, or metastatic lung nodules are
present. The confirmative diagnostic tool is a pathological
examination of a lung biopsy. In this case, an open lung
biopsy was performed, which resulted in the diagnosis of
PLCH based on positive staining for S-100 protein. The
only treatment was smoking cessation, and clinical and
radiological improvement was observed 15 months later.
This suggests that the nodular lesions of the PLCH were in
the reversible stage.
Here, we report a case of early stage PLCH in a young
male that had atypical radiological features, which consisted
of variable-sized nodules only without cystic changes.
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